| BCBS Florida Coverage Guidelines | Sarilumab (Kevzara®) Injection (09-J2000-88) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Secukinumab (Cosentyx®) Injection and (09-J2000-30) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Spesolimab-sbzo (Spevigo®) Subcutaneous (09-J4000-36) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Step Therapy Requirements for Medicare (09-J3000-39) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Surgical Treatments for Lymphedema and (02-12000-18) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Technologies for the Evaluation of Malignant (01-96900-03) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Telisotuzumab Vedotin (Emrelis) IV infusion (09-J5000-24) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tildrakizumab-asmn (Ilumya®) Injection (09-J3000-04) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tocilizumab Products (Actemra and Tyenne (09-J1000-21) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tralokinumab-ldrm (Adbry®) Injection (09-J4000-20) | 2026-01-01 |